- Home
- SAGE vs GRPN Comparison
SAGE vs GRPN Comparison
Compare SAGE & GRPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAGE
- GRPN
- Stock Information
- Founded
- SAGE 2010
- GRPN 2008
- Country
- SAGE United States
- GRPN United States
- Employees
- SAGE N/A
- GRPN N/A
- Industry
- SAGE Biotechnology: Pharmaceutical Preparations
- GRPN Advertising
- Sector
- SAGE Health Care
- GRPN Consumer Discretionary
- Exchange
- SAGE Nasdaq
- GRPN Nasdaq
- Market Cap
- SAGE 415.0M
- GRPN 791.8M
- IPO Year
- SAGE 2014
- GRPN 2011
- Fundamental
- Price
- SAGE $6.71
- GRPN $24.21
- Analyst Decision
- SAGE Hold
- GRPN Buy
- Analyst Count
- SAGE 19
- GRPN 4
- Target Price
- SAGE $9.88
- GRPN $17.25
- AVG Volume (30 Days)
- SAGE 934.8K
- GRPN 1.7M
- Earning Date
- SAGE 04-29-2025
- GRPN 05-07-2025
- Dividend Yield
- SAGE N/A
- GRPN N/A
- EPS Growth
- SAGE N/A
- GRPN N/A
- EPS
- SAGE N/A
- GRPN N/A
- Revenue
- SAGE $47,404,000.00
- GRPN $486,660,000.00
- Revenue This Year
- SAGE $100.64
- GRPN $2.91
- Revenue Next Year
- SAGE $70.19
- GRPN $6.73
- P/E Ratio
- SAGE N/A
- GRPN N/A
- Revenue Growth
- SAGE N/A
- GRPN N/A
- 52 Week Low
- SAGE $4.62
- GRPN $7.75
- 52 Week High
- SAGE $14.56
- GRPN $24.36
- Technical
- Relative Strength Index (RSI)
- SAGE 35.06
- GRPN 75.95
- Support Level
- SAGE $7.23
- GRPN $16.42
- Resistance Level
- SAGE $7.63
- GRPN $18.71
- Average True Range (ATR)
- SAGE 0.29
- GRPN 1.47
- MACD
- SAGE -0.09
- GRPN 0.09
- Stochastic Oscillator
- SAGE 0.38
- GRPN 98.15
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.
About GRPN Groupon Inc.
Groupon Inc acts as the middleman between consumers and merchants, offering products and services at discounts via its online store. It offers consumers daily deals from local merchants. The company's operations are organized into two segments: North America and International. The company generates the majority of its revenue from North America. The company generates revenue from transactions during which the company generates commissions by selling goods or services on behalf of third-party merchants. Revenue also includes commissions the company earn when customers make purchases with retailers using digital coupons accessed through its digital properties.